Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice

Neuroscience Letters

Volumn 373, Issue 3, 2005, Pages 237-242

  Van Den Buuse, Maarten ^a,b   Van Driel, Ian R ^b   Samuelson, Linda C ^c   Pijnappel, Meggie ^a   Martin, Sally ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Behaviour; Dopamine; Gastrin; Knockout mice; Prepulse inhibition; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; APOMORPHINE; DIZOCILPINE; DOPAMINE RECEPTOR BLOCKING AGENT; GASTRIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN 1A AGONIST; DIZOCILPINE MALEATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; FEMALE; GENOTYPE; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; MOUSE MUTANT; PHYSIOLOGY;

AMPHETAMINE; ANIMALS; DIZOCILPINE MALEATE; FEMALE; GASTRINS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; STARTLE REACTION;

EID: 16644361802     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.10.013     Document Type: Article

References (39)

1. A. Botella, M. Delvaux, P. Berry, J. Frexinos, L. Bueno, Cholecystokinin and gastrin induced cell contraction in pig ileum by interacting with different receptor subtypes, Gastroenterology 102 (1992) 779-786.
2. M. Bourin, M. Malinge, E. Vasar, J. Bradwejn, Two faces of cholecystokinin: anxiety and schizophrenia, Fundam. Clin. Pharmacol. 10 (1996) 116-126.
3. J. Crawley, Cholecystokinin modulates dopamine-mediated behaviours. Differential actions in medial posterior versus anterior nucleus accumbens, Ann. NY Acad. Sci. 713 (1994) 138-142.
4. I. Creese, S.D. Iversen, The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res. 83 (1975) 419-436.
5. V. Daugé, F. Beslot, T. Matsui, B.P. Roques, Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine, Neurosci. Lett. 306 (2001) 41-14.
6. V. Daugé, A. Samir, A. Cupo, B.P. Roques, Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat, Neuropharmacology 38 (1999) 999-1007.
7. A. de Weerth, L. Jonas, R. Schade, T. Schoneberg, G. Wolf, A. Pace, F. Kirchhoff, M. Schulz, T. Heinig, H. Greten, T. von Schrenck, Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization, Eur. J. Clin. Invest. 28 (1998) 592-601.
8. W.C. Drevets, C. Gautier, J.C. Price, D.J. Kupfer, P.E. Kinahan, A.A. Grace, J.L. Price, C.A. Mathis, Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria, Biol. Psychiatry 49 (2001) 81-96.
9. D. Feifel, T. Reza, S. Robeck, Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis, Neuropsychopharmacology 20 (1999) 141-149.
10. D. Feifel, N.R. Swerdlow, The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin, Neurosci. Lett. 229 (1997) 5-8.
11. P.W. Frankland, S.A. Josselyn, J. Bradwejn, F.J. Vaccarino, J.S. Yeomans, Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat, J. Neurosci. 17 (1997) 1838-1847.
12. L. Friis-Hansen, F. Sundler, Y. Li, P.J. Gillespie, T.L. Saunders, J.K. Greenson, C. Owyang, J.F. Rehfeld, L.C. Samuelson, Impaired gastric acid secretion in gastrin-deficient mice, Am. J. Physiol. 274 (1998) G561-G568.
13. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, N.R. Swerdlow, Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review, Psychopharmacology (2001) 156.
14. M.A. Geyer, A. Markou, Animal models of psychiatric disorders, in: FE. Bloom, D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 787-798.
15. M.A. Geyer, K.L. McIlwain, R. Paylor, Mouse genetic models for prepulse inhibition: an early review, Mol. Psychiatry (2002) 7.
16. J.R. Grider, G.M. Makhlouf, Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder, Am. J. Physiol. 259 (1990) G184-G190.
17. K.L. Hinkle, L.C. Samuelson, Lessons from genetically engineered animal models. III. Lessons learned from gastrin gene deletion in mice, Am. J. Physiol. 277 (1999) G500-G505.
18. M. Ito, T. Matsui, T. Taniguchi, T. Tsukamoto, T. Murayama, N. Arima, H. Nakata, T. Chiba, K. Chihara, Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin, J. Biol. Chem. (1993) 268.
19. S.A. Josselyn, V.P. Franco, F.J. Vaccarino, PD-135158, a CCKB receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior, Neurosci. Lett. (1996) 209.
20. P.H. Kelly, P.W. Seviour, S.D. Iversen, Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res. 94 (1975) 507-522.
21. M. Koch, The neurobiology of startle, Prog. Neurobiol. 59 (1999) 107-128.
22. M. Koch, H.U. Schnitzler, The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation, Behav. Brain Res. 89 (1997) 35-49.
23. T.J. Koh, Extragastic effects of gastrin gene knock-out mice, Pharmacol. Toxicol. 91 (2002) 368-374.
24. S. Koks, U. Abramov, A. Veraksits, M. Bourin, T. Matsui, E. Vasar, CCK2 receptor-deficient mice have increased sensitivity of dopamine D2 receptors, Neuropeptides 37 (2003) 25-29.
25. N. Ladurelle, B. Eychenne, D. Denton, J. Blair-West, M. Schumacher, P. Robel, E. Baulieu, Prolonged intracerebroventricular infusion of neurosteriods affects cognitive performances in the mouse, Brain Res. 858 (2000) 371-379.
26. N. Ladurelle, G. Keller, A. Blommaert, B.P. Roques, V. Dauge, The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats, Eur. J. Neurosci. 9 (1997) 1804-1814.
27. J.M. Lay, C. Jenkins, L. Friis-Hansen, L.C. Samuelson, Structure and developmental expression of the mouse CCK-B receptor gene, Biochem. Biophys. Res. Commun. 272 (2000) 842-872.
28. N.P. Nair, S. Lal, D.M. Bloom, Cholecystokinin peptides, dopamine and schizophrenia-a review, Prog. Neuropsychopharmacol. Biol. Psychiatry 9 (1985) 515-524.
29. J.F. Rehfeld, Progastrin and its products in the cerebellum, Neuropeptides 20 (1991) 239-245.
30. S. Rotzinger, D.E. Bush, F.J. Vaccarino, Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour, Pharmacol. Toxicol. 91 (2002) 404-413.
31. C. Saillan-Barreau, M. Dufresne, P. Clerc, D. Sanchez, C. Corominola, C. Moriscot, O. Guy-Crotte, C. Escrieut, N. Vaysse, R. Gomis, N. Tarasova, D. Fourmy, Evidence for a functional role of cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas, Diabetes 48 (1999) 2015-2021.
32. W.K. Samson, M.D. Lumpkin, E. Vijayan, S.M. McCann, Gastrointestinal hormones: central nervous system localization and sites of neuroendocrine actions, Endocrinol. Exp. 16 (1982) 177-189.
33. N.R. Swerdlow, R.S. Mansbach, M.A. Geyer, L. Pulvirenti, G.F. Koob, D.L. Braff, Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine, Psychopharmacology 100 (1990) 413-416.
34. S. Tanganelli, K. Fuxe, T. Antonelli, W.T. O'Connor, L. Ferraro, Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates, Peptides 22 (2001) 1229-1234.
35. M. Van den Buuse, N. Eikelis, Estrogen increases prepulse inhibition of acoustic startle in rats, Eur. J. Pharmacol. 425 (2001) 33-41.
36. M. Van den Buuse, E.R. Simpson, M.E. Jones, Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender, Genes Brain Behav. 2 (2003) 93-102.
37. J.J. Vanderhaeghen, S. Goldman, F. Lotstra, O. Van Reeth, C. Deschepper, J. Rossier, S. Schiffmann, Co-existence of cholecystokinin- or gastrin-like peptides with other peptides in the hypophysis and the hypothalamus, Ann. NY Acad. Sei. 448 (1985) 334-344.
38. E. Vasar, J. Harro, A. Lang, A. Fold, A. Soosaar, Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse, Psychopharmacology 105 (1991) 393-399.
39. J.H. Wang, J.L. Short, C. Ledent, A.J. Lawrence, M. van den Buuse, Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor, Behav. Brain Res. 143 (2003) 201-207.